| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,686 |
18,526 |
$1.07M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,629 |
5,159 |
$401K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,088 |
2,927 |
$275K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,363 |
2,233 |
$99K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,301 |
2,196 |
$68K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
451 |
415 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,008 |
1,895 |
$30K |
| 96127 |
|
3,081 |
2,815 |
$29K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,577 |
1,484 |
$27K |
| 99384 |
|
132 |
122 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
6,782 |
6,214 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
365 |
340 |
$13K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,286 |
1,158 |
$6K |
| 99215 |
Prolong outpt/office vis |
66 |
65 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
497 |
395 |
$6K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
291 |
276 |
$5K |
| 0012A |
|
150 |
148 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
45 |
43 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
66 |
62 |
$4K |
| 0011A |
|
162 |
154 |
$3K |
| 81025 |
|
359 |
324 |
$3K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
88 |
84 |
$1K |
| 90756 |
|
110 |
106 |
$1K |
| 94010 |
|
43 |
42 |
$1K |
| 87807 |
|
76 |
71 |
$939.07 |
| 81002 |
|
651 |
611 |
$920.21 |
| 90686 |
|
237 |
233 |
$564.53 |
| 99000 |
|
306 |
289 |
$553.70 |
| 0064A |
|
16 |
14 |
$480.00 |
| 93000 |
|
17 |
15 |
$301.00 |
| 90656 |
|
12 |
12 |
$104.10 |
| 90715 |
|
52 |
49 |
$95.22 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
13 |
$21.02 |
| 90651 |
|
100 |
98 |
$0.00 |
| 91301 |
|
334 |
318 |
$0.00 |
| 90674 |
|
80 |
76 |
$0.00 |
| 3074F |
|
15 |
14 |
$0.00 |
| 90734 |
|
70 |
69 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
475 |
455 |
$0.00 |
| 90661 |
|
13 |
13 |
$0.00 |
| 3078F |
|
14 |
12 |
$0.00 |